CERSCI THERAPEUTICS INC has a total of 21 patent applications. Its first patent ever was published in 2018. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and medical technology are DEZIMA PHARMA B V, SYNAPTEC DEV LLC and VIRONOVA HERPES AB.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | Australia | 1 | |
#4 | Brazil | 1 | |
#5 | Canada | 1 | |
#6 | China | 1 | |
#7 | EPO (European Patent Office) | 1 | |
#8 | Israel | 1 | |
#9 | Republic of Korea | 1 | |
#10 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Medical technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds | |
#4 | Organic chemistry methods | |
#5 | Syringes | |
#6 | Electrotherapy |
# | Name | Total Patents |
---|---|---|
#1 | Dax Scott L | 17 |
#2 | Confalone Pasquale N | 9 |
#3 | Dax Scott | 1 |
#4 | Scott L Dax | 1 |
#5 | Robbins Dennis I | 1 |
#6 | Pasquale N Confalone | 1 |
#7 | Hitt Ii David H | 1 |
Publication | Filing date | Title |
---|---|---|
US2020354328A1 | Manufacturing methods and polymorphs of a thiazoline anti-hyperalgesic agent | |
US2020246317A1 | Methods of treating diabetic neuropathy with a thiazoline anti-hyperalgesic agent | |
WO2020159565A1 | Methods of treating post-surgical pain with a thiazoline anti-hyperalgesic agent | |
AU2019279761A1 | Compounds for pain treatment, compositions comprising same, and methods of using same | |
US2018369133A1 | AMPK agonist topical medication for the treatment of certain specific medical conditions, methods of use thereof and wound dressing employing the same |